Physician profile
Marc J Berman
NPI 1356563340
$871.93
in general payments reported to CMS, 2019-2025
16 companies · $332 in 2025
The $332 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $93.34 · 2020: $249 · 2021: $44.92 · 2023: $98.08 · 2024: $54.38 · 2025: $332.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $485.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $484.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $211.30 | 2023-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Gilead Sciences, INC. | $191.39 | 2020 | |
| Medtronic, INC. | $100.53 | 2025 | Venaseal, Minimed 780g |
| Avita Medical Americas, LLC | $71.49 | 2024-2025 | Cohealyx, Permeaderm, Recell |
| Acera Surgical, INC. | $55.29 | 2023 | Restrata Wound Matrix |
| Amarin Pharma, INC. | $42.45 | 2020 | |
| Viiv Healthcare Company | $29.92 | 2021 | |
| Kerecis Limited | $28.28 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Lilly USA, LLC | $27.35 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $27.26 | 2019 | |
| Hydrofera LLC | $17.96 | 2024 | Hydrofera Blue |
| Depuy Synthes Sales INC. | $15.07 | 2019 | |
| Novo Nordisk INC | $14.98 | 2020 | |
| Wright Medical Technology, INC. | $14.19 | 2019 | |
| Glaxosmithkline, LLC. | $12.50 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $11.97 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marc Berman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.